Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Regenxbio (RGNX) Non-Current Receivables (2018 - 2025)

Regenxbio has reported Non-Current Receivables over the past 8 years, most recently at $2.3 million for Q4 2025.

  • Quarterly results put Non-Current Receivables at $2.3 million for Q4 2025, up 387.76% from a year ago — trailing twelve months through Dec 2025 was $2.3 million (up 387.76% YoY), and the annual figure for FY2025 was $2.3 million, up 387.76%.
  • Non-Current Receivables for Q4 2025 was $2.3 million at Regenxbio, down from $2.8 million in the prior quarter.
  • Over the last five years, Non-Current Receivables for RGNX hit a ceiling of $6.0 million in Q2 2022 and a floor of $404000.0 in Q3 2024.
  • Median Non-Current Receivables over the past 5 years was $1.5 million (2022), compared with a mean of $2.1 million.
  • Biggest five-year swings in Non-Current Receivables: tumbled 81.58% in 2023 and later soared 584.41% in 2025.
  • Regenxbio's Non-Current Receivables stood at $3.8 million in 2021, then crashed by 59.98% to $1.5 million in 2022, then tumbled by 53.39% to $701000.0 in 2023, then crashed by 32.38% to $474000.0 in 2024, then soared by 387.76% to $2.3 million in 2025.
  • The last three reported values for Non-Current Receivables were $2.3 million (Q4 2025), $2.8 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.